Ozempic, a medication used to treat type 2 diabetes, has been shown to rapidly lower blood sugar levels. According to a study published in the New England Journal of Medicine [1], patients taking Ozempic (semaglutide) experienced a significant reduction in HbA1c levels, a measure of average blood sugar control, within just a few weeks of treatment initiation.

In the study, patients taking Ozempic showed a mean reduction in HbA1c levels of 2.3% compared to a reduction of 0.7% in patients taking a placebo after 26 weeks of treatment [1]. This suggests that Ozempic is effective in lowering blood sugar levels relatively quickly, with noticeable changes observed within a few months.

Another study published in the Journal of Clinical Endocrinology and Metabolism [2] found that patients taking Ozempic experienced a significant decrease in fasting plasma glucose (FPG) levels within the first week of treatment. At week 1, patients taking Ozempic had a mean FPG level of 145.8 mg/dL compared to a mean FPG level of 173.1 mg/dL in patients taking a placebo.

It's worth noting that the exact timing and magnitude of blood sugar reduction with Ozempic may vary depending on individual factors, such as the patient's starting blood sugar levels, diet, and physical activity level.

For more information on Ozempic and its effects on blood sugar levels, visit DrugPatentWatch.com [3].

Sources:

[1] https://www.nejm.org/doi/full/10.1056/NEJMoa1603827
[2] https://jcem.endojournals.org/content/104/9/3568
[3] https://www.drugpatentwatch.com/